Emcyt (estramustine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Emcyt (estramustine), covering 2014-01-06 to 2014-01-06. Get the full timeline:
Most recent: Clinical Trial Update: Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [Phase 1, Phase 2]